# Radical Lung Radiotherapy Plus Nelfinavir

> **NCT01447589** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Oxford University Hospitals NHS Trust**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** nelfinavir
- **RADIATION:** Radical Radiotherapy

## Key facts

- **NCT ID:** NCT01447589
- **Lead sponsor:** Oxford University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-02
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** failed to recruit, no suitable patients
- **Last updated:** 2016-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447589, "Radical Lung Radiotherapy Plus Nelfinavir". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01447589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*